PHI with Liver dystrophy
How does this condition affect your private health insurance?
Leber's Hereditary Optic Neuropathy (LHON), or Leberdystrophie, is a mitochondrial genetic disorder primarily causing acute or subacute, painless vision loss, typically affecting young adult males. This progressive loss usually starts in one eye, followed by the other within weeks to months, leading to severe central vision impairment and optic atrophy. It results from specific mutations in mitochondrial DNA, leading to dysfunction of retinal ganglion cells and their axons. While some spontaneous partial recovery can occur, particularly with certain mutations, the vision loss is largely irreversible and significantly impacts quality of life, often leading to functional blindness.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
The acute phase of vision loss in each eye typically develops over days to several weeks or a few months.
Duration of Illness (Lifetime)
LHON is a chronic, lifelong condition once vision loss manifests. The visual impairment is generally permanent.
Cost of Treatment (Initial)
Initial diagnostic costs, including ophthalmological and neurological evaluations, genetic testing, and imaging, can range from hundreds to several thousands of USD. If idebenone treatment is initiated, the cost dramatically increases, potentially to tens of thousands per year from the start.
Cost of Treatment (Lifetime)
Lifelong costs are substantial, encompassing ongoing specialist appointments, low-vision aids, rehabilitation services, and psychological support. Should idebenone be prescribed long-term, annual costs can easily exceed hundreds of thousands of USD, making overall lifetime costs very high.
Mortality Rate
The probability of death directly attributable to classic Leberdystrophie is negligible. It is not a life-threatening disease, though rare associated systemic conditions might indirectly impact lifespan.
Risk of Secondary Damages
High probability of severe visual impairment leading to functional blindness and significant disability. There is also a high probability of psychological damage, including depression and anxiety, due to vision loss. A small probability exists for associated neurological (e.g., tremors, neuropathy) or cardiac conduction abnormalities, depending on the specific mitochondrial mutation.
Probability of Full Recovery
Probability of complete recovery is very low. Spontaneous partial vision recovery occurs in a minority of cases (ranging from 10% to 50% depending on the specific mutation), but full restoration of normal vision is extremely rare.
Underlying Disease Risk
LHON itself is a primary genetic disease. It is not typically caused by other underlying diseases. However, certain LHON-causing mitochondrial mutations can rarely be associated with broader systemic manifestations, such as cardiac conduction defects or neurological disorders (e.g., multiple sclerosis-like illness), making them components of a more extensive mitochondrial disease.